Trial of Roflumilast in Asthma Management (TRIM)
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2019
Price : $35 *
At a glance
- Drugs Roflumilast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms TRIM
- 27 Aug 2018 Planned primary completion date changed from 1 Oct 2019 to 1 Apr 2020.
- 16 Aug 2018 Status changed from not yet recruiting to recruiting.
- 24 May 2018 New trial record